Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 870 participants.
Also called NCT07135089
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 870 participants
- Registry
-
NCT07135089
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07135089. Randomized; quadruple masking; primary purpose treatment. Start 2025-11-13 (actual); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban
- Acronym
- INSIST-IT2
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Intravenous tirofiban before endovascular thrombectomy
- Intervention (Drug)
- Intravenous placebo before endovascular thrombectomy
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct07135089- Content hash
2e688df041b312e883ebef74de045e740208aa5a7f03e0b7efb0874bc047d328